Company / Operating Income per Share
Arcadia Biosciences, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.67
FY2025
5-year range
-$64.06 / -$0.95
FY2021-FY2025
Trend
+43.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has increased for 3 consecutive years, from $-64.06 in FY2022 to $-2.67 in FY2025.
Based on SEC 10-K filings.
-2.67 in FY2025.
Improved from $-22.74 to $-2.67 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 43.7% year-over-year.
- Peak operating income per share was recorded in FY2016.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.67 | +43.7% |
| FY2024 | -$4.75 | +79.1% |
| FY2023 | -$22.74 | +64.5% |
| FY2022 | -$64.06 | -6642.9% |
| FY2021 | -$0.95 | +57.6% |
| FY2020 | -$2.24 | +36.6% |
| FY2019 | -$3.53 | +47.3% |
| FY2018 | -$6.71 | +19.9% |
| FY2017 | -$8.37 | -2276.5% |
| FY2016 | -$0.35 | +95.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026